Relation Between Vascular Endothelial Growth Factor-A and the Severity of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus
(2022). Relation Between Vascular Endothelial Growth Factor-A and the Severity of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus. EKB Journal Management System, 2(2), -. doi: 10.21608/esdlj.2022.455805
. "Relation Between Vascular Endothelial Growth Factor-A and the Severity of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus". EKB Journal Management System, 2, 2, 2022, -. doi: 10.21608/esdlj.2022.455805
(2022). 'Relation Between Vascular Endothelial Growth Factor-A and the Severity of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus', EKB Journal Management System, 2(2), pp. -. doi: 10.21608/esdlj.2022.455805
Relation Between Vascular Endothelial Growth Factor-A and the Severity of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus. EKB Journal Management System, 2022; 2(2): -. doi: 10.21608/esdlj.2022.455805

Relation Between Vascular Endothelial Growth Factor-A and the Severity of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus

Egyptian Society of Diabetes and Lipidology Journal
Volume 2, Issue 2, October 2022    PDF (661.14 K)
Document Type: Abstracts
DOI: 10.21608/esdlj.2022.455805
Abstract
Diabetic peripheral neuropathy (DPN) is a common microvascular complication in patients with type 2 diabetes mellitus (T2DM). Vascular endothelial growth factor (VEGF) is an essential growth factor for vascular endothelial cells. We aimed in this study to investigate the relation between VEGF-A serum level and the degree of DPN.
Statistics
Article View: 30
PDF Download: 10